Список литературы на тему сахарного диабета у детей

Генератор титульных листов

Таблица истинности ONLINE

Сахарный диабет

1. Антонова, Р.П. Лечебное питание на дому для больных сахарным диабетом и ожирением / Р.П. Антонова. – М.: Профи-информ, 2019. – 332 c.

2. Булынко, С.Г. Диета и лечебное питание при ожирении и сахарном диабете / С.Г. Булынко. – Москва: Мир, 2016. – 256 c.

3. Васютин, А.М. Верни радость жизни, или Как избавиться от сахарного диабета / А.М. Васютин. – М.: Феникс, 2019. – 256 c.

4. Генес, С. Г. Пероральное лечение сахарного диабета / С.Г. Генес. – М.: Государственное медицинское издательство УССР, 2017. – 280 c.

5. Гурвич, М.М. Диета при сахарном диабете / М.М. Гурвич. – М.: ГЭОТАР-Медиа, 2018. – 820 c.

6. Довлатян, А.А. Почечные осложнения сахарного диабета: моногр. / А.А. Довлатян. – М.: Бином. Лаборатория знаний, 2020. – 577 c.

7. Домашнее лечение сахарного диабета. – М.: Антис, 2019. – 498 c.

8. Древаль, А. В. Профилактика поздних макрососудистых осложнений сахарного диабета / А.В. Древаль, И.В. Мисникова, Ю.А. Ковалева. – М.: ГЭОТАР-Медиа, 2017. – 331 c.

9. Дубровская, С. В. Здоровье и питание. Лечебное питание при сахарном диабете / С.В. Дубровская. – М.: Рипол Классик, 2017. – 192 c.

10. Зак, К.П. Иммунитет у детей, больных сахарным диабетом / К.П. Зак, Т.Н. Малиновская, Н.Д. Тронько. – М.: Книга плюс, 2019. – 112 c.

11. Ирина, Летова Лучшие рецепты здоровья при сахарном диабете / Летова Ирина. – М.: Диля, 2017. – 580 c.

12. Калугина, Л. А. Питание при сахарном диабете / Л.А. Калугина. – М.: Аделант, 2018. – 384 c.

13. Круглов, В.И. Диагноз: сахарный диабет / В.И. Круглов. – М.: Феникс, 2020. – 225 c.

14. Литагент, «Издательство Аделант» Питание при сахарном диабете / Литагент «Издательство Аделант». – М.: ИЗДАТЕЛЬСТВО АДЕЛАНТ, 2017. – 397 c.

15. Наумов, К. М. Поражение нервной системы при сахарном диабете / К.М. Наумов. – М.: Нордмедиздат, 2017. – 522 c.

16. Николайчук, Л. В. 1000 рецептов больным сахарным диабетом: моногр. / Л.В. Николайчук, Н.П. Зубицкая. – М.: Книжный дом, 2020. – 160 c.

17. Новые технологии в оперативной пародонтологии в комплексном лечении пациентов с сахарным диабетом 2 типа / Б.Т. Мороз и др. – М.: Типография “Наука”, 2020. – 160 c.

18. Остроухова, Е. Н. Правильное питание при сахарном диабете / Е.Н. Остроухова. – М.: Диля, 2016. – 160 c.

19. Пигулевская, Ирина Незаменимая книга для диабетика. Все, что нужно знать о сахарном диабете / Ирина Пигулевская. – М.: Центрполиграф, 2016. – 192 c.

20. Полевая, Мария Золотой ус в лечении сахарного диабета / Мария Полевая. – М.: ИГ “Весь”, 2019. – 128 c.

21. Поражение нервной системы при сахарном диабете / М.М. Одинак и др. – М.: Нордмедиздат, 2020. – 216 c.

22. Поражения нижних конечностей при сахарном диабете / В.Б. Бреговский и др. – М.: Диля, 2015. – 272 c.

23. Прихожан, В. М. Поражение нервной системы при сахарном диабете (основы нейродиабетологии) / В.М. Прихожан. – М.: Медицина, 2018. – 296 c.

24. Румянцева, Т. Дневник диабетика. Дневник самоконтроля при сахарном диабете / Т. Румянцева. – М.: АСТ, Астрель-СПб, 2017. – 384 c.

25. Скоробогатова, Е. С. Инвалидность по зрению вследствие сахарного диабета: моногр. / Е.С. Скоробогатова. – М.: Медицина, 2018. – 208 c.

26. Смирнова, М.А. Лечебное питание. Рецепты полезных блюд при сахарном диабете: моногр. / М.А. Смирнова. – М.: Рипол Классик, 2018. – 269 c.

27. Смирнова, Марина Лечебное питание. Сахарный диабет: моногр. / Марина Смирнова. – М.: Рипол Классик, 2020. – 922 c.

28. Филатова, М.В. Оздоровительные упражнения при сахарном диабете / М.В. Филатова. – М.: АСТ, 2015. – 145 c.

29. Хюртер, П. Книга о сахарном диабете 1 типа. Для детей, подростков, родителей и других / П. Хюртер, Л. Трэвис. – М.: Книга по Требованию, 2017. – 194 c.

30. Царенко, С.В. Интенсивная терапия при сахарном диабете / С.В. Царенко. – М.: Медицина, 2018. – 866 c.

Внимание: данные, отмеченные красным цветом, являются недостоверными!

Книги, использованные при создании данного списка литературы:

Антонова Р.П.Лечебное питание на дому для больных сахарным диабетом и ожирением	Булынко С.Г.Диета и лечебное питание при ожирении и сахарном диабете	Васютин А.М.Верни радость жизни, или Как избавиться от сахарного диабета
Генес С. Г.Пероральное лечение сахарного диабета	Гурвич М.М.Диета при сахарном диабете	Довлатян А.А.Почечные осложнения сахарного диабета
[автор не указан]Домашнее лечение сахарного диабета	Древаль А. В., Мисникова И. В., Ковалева Ю. А.Профилактика поздних макрососудистых осложнений сахарного диабета	Дубровская С. В.Здоровье и питание. Лечебное питание при сахарном диабете
Зак К.П., Малиновская Т.Н., Тронько Н.Д.Иммунитет у детей, больных сахарным диабетом	Ирина ЛетоваЛучшие рецепты здоровья при сахарном диабете	Калугина Л. А.Питание при сахарном диабете
Круглов В.И.Диагноз: сахарный диабет	Наумов К. М.Поражение нервной системы при сахарном диабете	Николайчук Л. В., Зубицкая Н. П.1000 рецептов больным сахарным диабетом
Мороз Б. Т., Хромова Е. А., Шустов С. Б., др.Новые технологии в оперативной пародонтологии в комплексном лечении пациентов с сахарным диабетом 2 типа	Остроухова Е. Н.Правильное питание при сахарном диабете	Пигулевская Ирина Незаменимая книга для диабетика. Все, что нужно знать о сахарном диабете
Полевая Мария Золотой ус в лечении сахарного диабета	Бреговский В. Б., Зайцев А. А., Залевская А. Г., Карпов О. И., Карпова И. А., Цветкова Т. Л.Поражения нижних конечностей при сахарном диабете	Прихожан В. М.Поражение нервной системы при сахарном диабете (основы нейродиабетологии)
Румянцева Т.Дневник диабетика. Дневник самоконтроля при сахарном диабете	Скоробогатова Е. С.Инвалидность по зрению вследствие сахарного диабета	Смирнова М.А.Лечебное питание. Рецепты полезных блюд при сахарном диабете
Смирнова МаринаЛечебное питание. Сахарный диабет	Филатова М.В.Оздоровительные упражнения при сахарном диабете	Хюртер П., Трэвис Л.Книга о сахарном диабете 1 типа. Для детей, подростков, родителей и других
Царенко С.В.Интенсивная терапия при сахарном диабете

Источник

1. Staging Presymptomatic Type 1 Diabetes: A Scientific ement of JDRF, the Endocrine Society, and the American Diabetes Association/R.A. Insel [et al.]//Diabetes Care. – 2015. – Vol. 38. – N 10. – P. 1964 – 1974.

2. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children/A.G. Ziegler [et al.]//JAMA. – 2013. – Vol. 309. – N 23. – P. 2473.

3. Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013 – 2016)/A.Y. Mayorov [и др.]//Diabetes mellitus. – 2019. – T. 21. – N 6. – C. 444 – 454.

4. Trends in the epidemiology of diabetic retinopathy in Russian Federation according to the Federal Diabetes Register (2013 – 2016)/D.V. Lipatov [и др.]//Diabetes mellitus. – 2018. – T. 21. – N 4. – C. 230 – 240.

5. Trends in the epidemiology of diabetic foot and lower limb amputations in Russian Federation according to the Federal Diabetes Register (2013 – 2016)/G.R. Galstyan [и др.]//Diabetes mellitus. – 2018. – T. 21. – N 3. – C. 170 – 177.

6. Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013 – 2016)/M.S. Shamkhalova [и др.]//Diabetes mellitus. – 2018. – T. 21. – N 3. – C. 160 – 169.

7. Diabetes mellitus in children and adolescents according to the Federal diabetes registry in the Russian Federation: dynamics of major epidemiological characteristics for 2013 – 2016/I.I. Dedov [и др.]//Diabetes mellitus. – 2018. – T. 20. – N 6. – C. 392 – 402.

8. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of glycaemic control and structure of glucose lowering therapy according to the Federal Diabetes Register, us 2017/I.I. Dedov [и др.]//Diabetes mellitus. – 2018. – T. 21. – N 3. – C. 144 – 159.

9. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents/E.J. Mayer-Davis [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 7 – 19.

10. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018/American Diabetes Association//Diabetes Care. – 2018. – Vol. 41. – N Supplement 1. – P. S13 – S27.

11. World Health Organization. Definition and diagnosis of diabetes mellitus and interte hyperglycaemia: report of a WHO/IDF consultation/World Health Organization, International Diabetes Federation. – 2006.

12. Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review/R.A. Watkins [et al.]//Translational Re: The Journal of Laboratory and Clinical Medicine. – 2014. – Vol. 164. – N 2. – P. 110 – 121.

13. Etiological Approach to Characterization of Diabetes Type: The for Diabetes in Youth Study/D. Dabelea [et al.]//Diabetes Care. – 2011. – Vol. 34. – N 7. – P. 1628 – 1633.

14. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth/P. Zeitler [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 28 – 46.

15. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality/Writing Group for the DCCT/EDIC Re Group [et al.]//JAMA. – 2015. – Vol. 313. – N 1. – P. 45 – 53.

16. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort/Writing Team for the DCCT/EDIC Re Group [et al.]//JAMA ophthalmology. – 2016. – Vol. 134. – N 2. – P. 137 – 145.

17. Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012/B. Karges [et al.]//PLoS medicine. – 2014. – Vol. 11. – N 10. – P. e1001742.

18. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes/L.A. DiMeglio [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 105 – 114.

19. Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes/A. Fritsche [et al.]//Annals of Internal Medicine. – 2001. – Vol. 134. – N 9 Pt 1. – P. 729 – 736.

20. Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict bolic control: A multicentre analysis of 15 199 adult type 1 diabetes patients from Germany and Austria/A. Schwandt [et al.]//Diabetes/bolism Re and Reviews. – 2017. – Vol. 33. – N 7.

21. Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control/O.J. Driskell [et al.]//Diabetes Care. – 2014. – Vol. 37. – N 10. – P. 2731 – 2737.

22. A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus/M. Liu [et al.]//BMC endocrine disorders. – 2016. – Vol. 16. – N 1. – P. 67.

23. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus/E. Schober [et al.]//Journal of pediatric endocrinology & bolism: JPEM. – 2002. – Vol. 15. – N 4. – P. 369 – 376.

24. Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes/T. Danne [et al.]//Diabetes Care. – 2005. – Vol. 28. – N 9. – P. 2100 – 2105.

25. Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes/A. Philotheou [et al.]//Diabetes Technology & Therapeutics. – 2011. – Vol. 13. – N 3. – P. 327 – 334.

26. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents/J.H. Holcombe [et al.]//Clinical Therapeutics. – 2002. – Vol. 24. – N 4. – P. 629 – 638.

27. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus/S. Tupola [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2001. – Vol. 18. – N 8. – P. 654 – 658.

28. Effectiveness of postprandial Huma toddlers with diabetes/K.S. Rutledge [et al.]//Pediatrics. – 1997. – Vol. 100. – N 6. – P. 968 – 972.

29. Insulin Lispro Lowers Postprandial Glucose in Prepubertal Children With Diabetes/L.C. Deeb [et al.]//PEDIATRICS. – 2001. – Vol. 108. – N 5. – P. 1175 – 1179.

30. Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial/T. Battelino [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – N 7. – P. 1263 – 1270.

31. Switching From Glargine to Degludec: The Effect on bolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes/B. Predieri [и др.]//Frontiers in Endocrinology. – 2018. – T. 9. – C. 462.

32. The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials/N. Thalange [et al.]//Pediatric Diabetes. – 2019. – Vol. 20. – N 3. – P. 314 – 320.

33. Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes: IDeg effective and safe in pediatric T1D/N. Thalange [et al.]//Pediatric Diabetes. – 2015. – Vol. 16. – N 3. – P. 164 – 176.

34. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes/T. Danne [et al.]//Diabetes Care. – 2003. – Vol. 26. – N 11. – P. 3087 – 3092.

35. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes/K.J. Robertson [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2007. – Vol. 24. – N 1. – P. 27 – 34.

36. ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes/T. Danne [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 115 – 135.

37. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Re Group//The Journal of Pediatrics. – 1994. – Vol. 125. – N 2. – P. 177 – 188.

38. Impact of diabetes and its treatment on cognitive among adolescents who participated in the Diabetes Control and Complications Trial/G. Musen [et al.]//Diabetes Care. – 2008. – Vol. 31. – N 10. – P. 1933 – 1938.

39. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)/N.H. White [et al.]//The Journal of Pediatrics. – 2001. – Vol. 139. – N 6. – P. 804 – 812.

40. Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)/R. Pop-Busui [et al.]//Circulation. – 2009. – Vol. 119. – N 22. – P. 2886 – 2893.

41. Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Geional Diabetes: Systematic Review and -Analysis/K. [et al.]//Diabetes Therapy. – 2018. – Vol. 9. – N 3. – P. 891 – 917.

42. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin/H.P. Chase [et al.]//The Journal of Pediatrics. – 2003. – Vol. 143. – N 6. – P. 737 – 740.

43. Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство./Майоров А.Ю. [и др.]. – Москва: ООО “АРТИНФО”, 2018. – 64 с.

44. New Insulin Delivery ations/A.H. Frid [et al.]//Mayo Clinic Proceedings. – 2016. – Vol. 91. – N 9. – P. 1231 – 1255.

45. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants/K.M. Miller [et al.]//Diabetes Care. – 2013. – Vol. 36. – N 7. – P. 2009 – 2014.

46. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes/R. Ziegler [et al.]//Pediatric Diabetes. – 2011. – Vol. 12. – N 1. – P. 11 – 17.

47. 20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes/B. Bohn [et al.]//PloS One. – 2016. – Vol. 11. – N 8. – P. e0160971.

48. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial/T. Battelino [et al.]//Diabetologia. – 2012. – Vol. 55. – N 12. – P. 3155 – 3162.

49. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real- Continuous Glucose Monitoring/A.H. El-Laboudi [et al.]//Diabetes Technology & Therapeutics. – 2016. – Vol. 18. – N 12. – P. 806 – 812.

50. Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study: Results from the 6-month continuation phase/R.M. Bergenstal [et al.]//Diabetes Care. – 2011. – Vol. 34. – N 11. – P. 2403 – 2405.

51. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents/H. Phelan [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 75 – 83.

52. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and -analysis of randomised controlled trials/K. Winkley [et al.]//BMJ (Clinical re ed.). – 2006. – Vol. 333. – N 7558. – P. 65.

53. Effects of educational and psycho interventions for adolescents with diabetes mellitus: a systematic review/S.E. Hampson [et al.]//Health Technology Assessment (Winchester, England). – 2001. – Vol. 5. – N 10. – P. 1 – 79.

54. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial/DAFNE Study Group//Diabetic Medicine: A Journal of the British Diabetic Association. – 2003. – Vol. 20 Suppl 3. – P. 4 – 5.

55. Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and -analysis of randomized control trials/E. [et al.]//Pediatric Diabetes. – 2009. – Vol. 10. – N 1. – P. 52 – 58.

56. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and -analysis/K. Benkhadra [et al.]//Endocrine. – 2017. – Vol. 55. – N 1. – P. 77 – 84.

57. Pickup, J.C. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: -analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion/J.C. Pickup, A.J. Sutton//Diabetic medicine: a journal of the British Diabetic Association. – 2008. – Vol. 25. – N 7. – P. 765 – 774.

58. The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on bolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes/M.D.R. Vallejo-Mora [et al.]//Journal of Diabetes. – 2017. – Vol. 9. – N 1. – P. 24 – 33.

59. Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study)/M.D.R. Vallejo Mora [et al.]//Diabetes Technology & Therapeutics. – 2017. – Vol. 19. – N 7. – P. 402 – 409.

60. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial/R. Ziegler [et al.]//Diabetes Care. – 2013. – Vol. 36. – N 11. – P. 3613 – 3619.

61. Use of an automated bolus calculator in MDI-treated type 1 diabetes: the BolusCal Study, a randomized controlled pilot study/S. Schmidt [et al.]//Diabetes Care. – 2012. – Vol. 35. – N 5. – P. 984 – 990.

62. The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus – systematic review/A. Ramotowska [et al.]//Experimental and Clinical Endocrinology & Diabetes: Official Journal, German Society of Endocrinology [and] German Diabetes Association. – 2013. – Vol. 121. – N 5. – P. 248 – 254.

63. A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data/J.C. Wong [et al.]//Diabetes Technology & Therapeutics. – 2015. – Vol. 17. – N 8. – P. 555 – 562.

64. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study/R.H. Slover [et al.]//Pediatric Diabetes. – 2012. – Vol. 13. – N 1. – P. 6 – 11.

65. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial/T.T. Ly [et al.]//JAMA. – 2013. – Vol. 310. – N 12. – P. 1240 – 1247.

66. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes/M.B. Abraham [et al.]//Diabetes Care. – 2018. – Vol. 41. – N 2. – P. 303 – 310.

67. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial/T. Battelino [et al.]//Diabetes Care. – 2017. – Vol. 40. – N 6. – P. 764 – 770.

68. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies/J.L. Sherr [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 302 – 325.

69. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes education in children and adolescents/H. Phelan [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 75 – 83.

70. , M. The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT/M. , E. //Pediatric Diabetes. – 2012. – Vol. 13. – N 7. – P. 534 – 539.

71. Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes/T. Battelino [et al.]//Diabetes Care. – 2011. – Vol. 34. – N 4. – P. 795 – 800.

72. Pickup, J.C. Glycaemic control in type 1 diabetes during real continuous glucose monitoring compared with self monitoring of blood glucose: -analysis of randomised controlled trials using individual patient data/J.C. Pickup, S.C. Freeman, A.J. Sutton//BMJ (Clinical re ed.). – 2011. – Vol. 343. – P. d3805.

73. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study/I.B. Hirsch [et al.]//Diabetes Technology & Therapeutics. – 2008. – Vol. 10. – N 5. – P. 377 – 383.

74. Use of the GlucoWatch biographer in children with type 1 diabetes/H.P. Chase [et al.]//Pediatrics. – 2003. – Vol. 111. – N 4 Pt 1. – P. 790 – 794.

75. A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects/F.R. Kaufman [et al.]//Diabetes Care. – 2001. – Vol. 24. – N 12. – P. 2030 – 2034.

76. Ludvigsson, J. Continuous subcutaneous glucose monitoring improved bolic control in pediatric patients with type 1 diabetes: a controlled crossover study/J. Ludvigsson, R. Hanas//Pediatrics. – 2003. – Vol. 111. – N 5 Pt 1. – P. 933 – 938.

77. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes/C.E. Smart [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 136 – 154.

78. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus/J.I. Mann [et al.]//Nutrition, bolism, and cardiovascular diseases: NMCD. – 2004. – Vol. 14. – N 6. – P. 373 – 394.

79. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial/L.M. Delahanty [et al.]//The American Journal of Clinical Nutrition. – 2009. – Vol. 89. – N 2. – P. 518 – 524.

80. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era/K.J. Bell [et al.]//Diabetes Care. – 2015. – Vol. 38. – N 6. – P. 1008 – 1015.

81. Nansel, T.R. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes/T.R. Nansel, L.M. Lipsky, A. Liu//The American Journal of Clinical Nutrition. – 2016. – Vol. 104. – N 1. – P. 81 – 87.

82. Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with Type 1 diabetes mellitus/M.A. Paterson [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2017. – Vol. 34. – N 6. – P. 851 – 854.

83. Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive/C.E.M. Smart [et al.]//Diabetes Care. – 2013. – Vol. 36. – N 12. – P. 3897 – 3902.

84. , E. Does the Fat-Protein Meal Increase Postprandial Glucose Level in Type 1 Diabetes Patients on Insulin Pump: The Conclusion of a Randomized Study/E. , M. , L. Groele//Diabetes Technology & Therapeutics. – 2012. – Vol. 14. – N 1. – P. 16 – 22.

85. Lessons from the Hvidoere International Study Group on childhood diabetes: be dogmatic outcome and flexible in approach: Hvidoere group studies/F. Cameron [et al.]//Pediatric Diabetes. – 2013. – Vol. 14. – N 7. – P. 473 – 480.

86. Physical activity interventions in children and young people with Type 1 diabetes mellitus: a systematic review with -analysis/H. Quirk [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – N 10. – P. 1163 – 1173.

87. A systematic review of physical activity and sedentary behavior intervention studies in youth with type 1 diabetes: study characteristics, intervention de, and efficacy/F. MacMillan [et al.]//Pediatric Diabetes. – 2014. – Vol. 15. – N 3. – P. 175 – 189.

88. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and -analysis/M. Nocon [et al.]//European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. – 2008. – Vol. 15. – N 3. – P. 239 – 246.

89. Riddell, M.C. Type 1 Diabetes and Vigorous Exercise: Applications of Exercise Physiology to Patient Management/M.C. Riddell, B.A. Perkins//Canadian Journal of Diabetes. – 2006. – Vol. 30. – N 1. – P. 63 – 71.

90. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes/P. Adolfsson [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 205 – 226.

91. Eating problems in adolescents with Type 1 diabetes: a systematic review with -analysis/V. Young [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2013. – Vol. 30. – N 2. – P. 189 – 198.

92. Depression and adherence to treatment in diabetic children and adolescents: a systematic review and -analysis of observational studies/C. Kongkaew [et al.]//European Journal of Pediatrics. – 2014. – Vol. 173. – N 2. – P. 203 – 212.

93. ISPAD Clinical Practice Consensus Guidelines 2018: The delivery of ambulatory diabetes care to children and adolescents with diabetes/C. Pihoker [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 84 – 104.

94. Microvascular complications assessment in adolescents with 2- to 5-yr duration of type 1 diabetes from 1990 to 2006/Y.H. Cho [et al.]//Pediatric Diabetes. – 2011. – Vol. 12. – N 8. – P. 682 – 689.

95. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents/K.C. Donaghue [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 262 – 274.

96. Type 1 Diabetes in Children and Adolescents: A Position ement by the American Diabetes Association/J.L. Chiang [et al.]//Diabetes Care. – 2018. – Vol. 41. – N 9. – P. 2026 – 2044.

97. Martinez-Zapata M. J. et al. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy//Cochrane Database of Systematic Reviews. – 2014. – N 11.

98. Simunovic, M. P., & Maberley, D. A. L. (2015). ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY. Retina, 35(10), 1931 – 1942. doi: 10.1097/iae.0000000000000723.

99. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus/J. Cook [et al.]//The Journal of Pediatrics. – 1990. – Vol. 117. – N 1. – P. 39 – 45.

100. Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect/S. Rudberg [et al.]//Diabetologia. – 1990. – Vol. 33. – N 8. – P. 470 – 476.

101. American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018/American Diabetes Association//Diabetes Care. – 2018. – Vol. 41. – N Supplement 1. – P. S105 – S118.

102. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension/B. Soffer [et al.]//American Journal of Hypertension. – 2003. – Vol. 16. – N 10. – P. 795 – 800.

103. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network -Analyses/F. [et al.]//PLOS Medicine. – 2016. – Vol. 13. – N 3. – P. e1001971.

104. Finn, B.P. Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes/B.P. Finn, B. Fraser, S.M. O’Connell//BMJ Case Reports. – 2018. – P. bcr-2017-222861.

105. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar e/J.I. Wolfsdorf [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 155 – 177.

106. ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes/M.B. Abraham [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 178 – 192.

107. Tinti, D. Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series/D. Tinti, I. Rabbone//Acta Diabetologica. – 2019.

108. Thyroid autoimmunity in Type 1 diabetes: systematic review and -analysis/C.B. Shun [et al.]//Diabetic Medicine: A Journal of the British Diabetic Association. – 2014. – Vol. 31. – N 2. – P. 126 – 135.

109. Lee, J.Y. Prognostic value of acoustic structure quantification in patients with Hashimoto’s thyroiditis/J.Y. Lee, H.S. Hong, C.-H. Kim//European Radiology. – 2019. – Vol. 29. – N 11. – P. 5971 – 5980.

110. ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes/F.H. Mahmud [et al.]//Pediatric Diabetes. – 2018. – Vol. 19. – P. 275 – 286.

111. Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review/A. Pham-Short [et al.]//PEDIATRICS. – 2015. – Vol. 136. – N 1. – P. e170 – e176.

112. Elkabbany Z. A. et al. Transient elastography as a noninvasive assessment for hepatopathies of different etiology in pediatric type 1 diabetes mellitus//Journal of Diabetes and its Complications. – 2017. – T. 31. – N. 1. – C. 186 – 194.

Источник